Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011849 (
diabetes
)
277,896
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Chromosome 6q24-related
diabetes mellitus
is the most common cause of transient neonatal
diabetes
(
TNDM
), accounting for approximately two-thirds of all
TNDM
cases. Patients with 6q24-
TNDM
develop insulin-requiring
diabetes
soon after birth, followed by the gradual improvement and eventual remission of the disorder by 18 mo of age. The most important clinical feature of affected patients is a small-for-gestational age (SGA) birth weight, which reflects the lack of insulin in utero. It is believed that 6q24-
TNDM
is caused by the overexpression of the paternal allele of the imprinted locus in chromosome 6q24, which contains only two expressed genes,
PLAGL1
and
HYMAI.
Identified mechanisms include: (1) duplication of the paternal allele, (2) paternal uniparental disomy, and (3) hypomethylation of the maternal allele. Many patients with
TNDM
relapse after puberty. Relapsed 6q24-related
diabetes
is no longer transient and typically occurs in non-obese patients who are autoantibody negative. Thus, these patients possess features indistinguishable from those of maturity-onset
diabetes
of the young (MODY). Conversely, it has been shown that not all patients with 6q24-related
diabetes
have a history of
TNDM
. 6q24-related
diabetes
should therefore be considered as one of the differential diagnoses for patients with MODY-like
diabetes
, especially when they are SGA at birth.
...
PMID:Chromosome 6q24-related diabetes mellitus. 2966 64
Congenital
diabetes mellitus
is a rare disorder characterized by hyperglycemia that occurs shortly after birth. We define "Diabetes of Infancy" if hyperglycemia onset before 6 months of life. From the clinical point of view, we distinguish two main types of
diabetes
of infancy: transient (
TNDM
), which remits spontaneously, and permanent (PNDM), which requires lifelong treatment.
TNDM
may relapse later in life. About 50% of cases are transient (
TNDM
) and 50% permanent. Clinical manifestations include severe intrauterine growth retardation, hyperglycemia and dehydration. A wide range of different associated clinical signs including facial dysmorphism, deafness and neurological, cardiac, kidney or urinary tract anomalies are reported. Developmental delay and learning difficulties may also be observed. In this paper we review all the causes of congenital
diabetes
and all genes and syndromes involved in this pathology. The discovery of the pathogenesis of most forms of congenital
diabetes
has made it possible to adapt the therapy to the diagnosis and in the forms of alteration of the potassium channels of the pancreatic Beta cells the switch from insulin to glibenclamide per os has greatly improved the quality of life. Congenital
diabetes
, although it is a very rare form, has been at the must of research in recent years especially for pathogenesis and pharmacogenetics. The most striking difference compared to the more frequent autoimmune
diabetes
in children (type 1 diabetes) is the possibility of treatment with hypoglycemic agents and the apparent lower frequency of chronic complications.
...
PMID:Congenital diabetes mellitus. 3227 16
The overexpression of imprinted genes on chromosome 6q24 causes 6q24-related transient neonatal
diabetes mellitus
(6q24-TNDM). Most cases of 6q24-
TNDM
show transient
diabetes mellitus
(DM) during the neonatal period, followed by relapse after puberty. These two courses of DM are both characterized by insulin insufficiency. However, there has been no previously reported case of 6q24-
TNDM
with insulin resistance at relapse. We report the case of a 10-yr-old Japanese girl with relapsing 6q24-
TNDM
. In the neonatal period, she had hyperglycemia and was treated with insulin injection until 2 mo of age. After several years of remission of DM, her HbA1c level increased to 7.4% at 10 yr of age. Homeostasis model assessment of insulin resistance (HOMA-IR) score was high at 6.2. After starting metformin therapy, her glycemic control improved along with normalization of HOMA-IR score. Using microsatellite marker analysis on the 6q24 region and array comparative genome hybridization, we diagnosed her with 6q24-
TNDM
due to paternally inherited duplication of 6q24. These data indicate that patients with 6q24-
TNDM
can develop relapsing DM with insulin resistance.
...
PMID:Relapsing 6q24-related transient neonatal diabetes mellitus with insulin resistance: A case report. 3308 17
<< Previous
1
2
3